Dare Bioscience
DARE
27 hedge funds and large institutions have $1.9M invested in Dare Bioscience in 2025 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 4 closing their positions.
175% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 4
29% more funds holding
Funds holding: 21 → 27 (+6)
0.58% less ownership
Funds ownership: 7.49% → 6.9% (-0.58%)
12% less capital invested
Capital invested by funds: $2.16M → $1.9M (-$254K)
33% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$256K |
| 2 |
Two Sigma Investments
New York
|
+$65.9K |
| 3 |
US Bancorp
Minneapolis,
Minnesota
|
+$41.7K |
| 4 |
Two Sigma Advisers
New York
|
+$35.7K |
| 5 |
LPL Financial
San Diego,
California
|
+$29.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$79K |
| 2 |
HighTower Advisors
Chicago,
Illinois
|
-$24.6K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
-$9.41K |
| 4 |
GRP
Global Retirement Partners
San Rafael,
California
|
-$9.15K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$3.4K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
II
26
Inspire Investing
Meridian,
Idaho
| $23 | +$24 | +12 | New |
|
|
CPG
27
Cornerstone Planning Group
Fairfield,
New Jersey
| $4 | -$489 | -245 | -99% |
|
|
28
HighTower Advisors
Chicago,
Illinois
| – | -$24.6K | -11,692 | Closed |
|
|
GRP
29
Global Retirement Partners
San Rafael,
California
| – | -$9.15K | -4,359 | Closed |
|
|
MG
30
Mather Group
Chicago,
Illinois
| – | -$176 | -84 | Closed |
|
31
Citigroup
New York
| – | -$4 | -2 | Closed |
|
DARE Hedge Fund Activity: Q4 2025 in Review
27 of the 8,232 institutional investors tracked by Wall St. Rank reported a position in Dare Bioscience (DARE) for Q4 2025, worth a combined $1.9M — down 12% from $2.16M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new DARE positions and 4 closed out — a net gain of 7 holders — while 4 added to existing stakes and 6 trimmed.
The largest buyer was Vanguard Group, adding an estimated $256K. The largest seller was Renaissance Technologies, cutting an estimated $79K.
- 27 institutional investors held Dare Bioscience (DARE) as of Q4 2025, up from 21 in Q3 2025.
- Funds reported $1.9M of Dare Bioscience stock for Q4 2025, down 12% quarter-over-quarter.
- 11 funds opened new Dare Bioscience positions in Q4 2025 and 4 closed out, a net change of +7 holders.
- The largest Dare Bioscience buyer in Q4 2025 was Vanguard Group, an estimated $256K added.
- The largest Dare Bioscience seller in Q4 2025 was Renaissance Technologies, an estimated $79K sold.
Based on aggregated 13F filings for Q4 2025.